Or I guess my next questions would be... If a p value isn't appropriate here what's the best way to present this data statistically?
Thanks again!!!
Hey guys
So I've been doing some medical research and I have a great result by no idea how to approach working out the P value.
Basically with a new technique we can reduce the number of subsequent (revisional) operation a patient needs. The data is as follow:
Old method
1 operation - 14
2 operations - 25
3 operations - 16
4 operations -5
New method
1 operation - 35
2 operations - 18
3 operations - 5
4 operations - 2
So we're really pleased that using the new method patients are needing less operations. I'm trying to write this up and get some sexy statistics with p values, CI and all that but I've been trying to teach myself how to do it for god knows how long and I'm real stumped...
Is there anyone that can help me and explain how to do this? (in non-statistician language :roll eyes
Thanks!!!
Or I guess my next questions would be... If a p value isn't appropriate here what's the best way to present this data statistically?
Thanks again!!!
So you have 60 patients in the historic group and 60 in the new method group and the above represent the counts of number of repetitive interventions that they needed?
Was the method randomized, can you be confident that there is no apparent of latent confounders?
I am thinking a Poisson regression would be your best bet given your basic description. Not a simple procedure to just jump into if you have a limited statistical back group. Also, it might not control for repeated events. Please tell us more about your study!
Stop cowardice, ban guns!
PKrazda (01-26-2017)
Thanks for getting back to me!
That's correct, we have 60 patients since a point in time at which we implemented the new technique. Fortunately we have a prospectively kept database of all patients, demographics and outcomes from which we collected data on the previous 60 patients having the same operation.
And yep you're right about the repetitive operation aspect. 'Operation one' was the initial operation and the subsequent operations are each to revise the initial op. So those having 'four operations' have had there initial op and 3 subsequent ops to alter/adjust the outcome of the first.
It wasn't randomised as the surgeon changed practice at the beginning of 2014 and our study is focusing solely on operations done by them to eliminate operating surgeon as a variable.
The study itself is looking at the aesthetic outcomes of a reconstructive surgical procedure. Quite interesting and if things go well could possibly change practice!
I've had a look at Poisson regression and it looks a little out of my comfort zone but if you think it's the way to go i'll read around it and see if I can grasp it to be used in our study. Any additional suggestions for ways to represent this kind of data? Was I right in that a p value wouldn't be much use here? I seem to se it used quite a lot representing this kind of data (i.e. 2 data sets, one pre and one post intervention), but can never really grasp hat it's trying to demonstrate.
Can I strongly suggest that you pre-register your protocol for data collection and analysis ahead of time for your next clinical trial? When you collect data and then only start to think about the analysis there is a major risk that (consciously or subconsiously) your data analytic decisions will be guided by whether a particular analysis method provides the findings you're hoping to see. It can be ok to figure out the analysis decisions as you go in an exploratory fashion in some contexts, but in clinical trials it's a really really big no-no nowadays.
http://www.talkstats.com/showthread....t-is-a-p-valueWas I right in that a p value wouldn't be much use here? I seem to se it used quite a lot representing this kind of data (i.e. 2 data sets, one pre and one post intervention), but can never really grasp hat it's trying to demonstrate.
I do suspect that if you're unsure about general statistical concepts that you probably would benefit from collaborating with a statistician on this project -
Is there any possibility of having a statistician join your project team here? Not knowing statistical concepts like p values is totally understandable, but clinical trials are important high-stakes research - it is important to get this stuff right. Having an expert on board could help a lot.
Matt aka CB | twitter.com/matthewmatix
PKrazda (01-28-2017)
Hi CowboyBear, thanks for getting back to me too
I take your point and am fully aware of interpretation bias when looking at data in the fashion. Unfortunately we just don't have anything close to the kind of funding one would need for a randomised controlled trial. Retrospective data analysis such as this are used by a huge number of people who want to push forward with ideas but do not have the means to use what in essence would be the 'right' way to do it. When presenting our data we will of course be upfront about the nature of data collection and the methodology used throughout and it's up to the reader to appreciate the inherent limitations in such a study.
Unfortunately whilst I would love the involvement of a statistician in our study, there is no chance that can happen as our institute just cannot stretch to it and we have experienced this with similar studies.
On that note would you be able to put forward any final suggestions on how to present this data i the most statistically effective way? I know it may be tricky given the simplicity of our data presentation.
Thanks again for your responses so far!
Oh totally I understand that not everyone can afford to run RCTs (my dept certainly can't!) But even if you have design that has, say, a non-randomised control group, it's still possible to pre-register your study protocol and analysis plan. That is, if the study is planned before data collection takes place. It's just something to think about for next time.
This sounds great, but you can help the reader further by also reporting several different ways of analysing the data so that they can see how robust the results are to different analysis techniques. In this case a Poisson regression seems like a good starting point, but maybe a negative binomial could work too, and you could even have an OLS/linear regression for comparison.When presenting our data we will of course be upfront about the nature of data collection and the methodology used throughout and it's up to the reader to appreciate the inherent limitations in such a study.
Matt aka CB | twitter.com/matthewmatix
On the face of it, it is hard to see what is wrong with a Chi square test.
The data is independent and each patient appears in one cell only. It's true that the test doesn't take into account the ordered nature of the data, but if you get a significant p value (and you will) that doesn't matter. Probably you should accumulate the 3 and 4 op patients into one 3+ group because the counts are low.
I'm trying to imagine the objections a referee might bring up.
It kinda sounds like you're saying that if the chi-square is significant then report that, but if it isn't then find something else? That's p-hacking, no?
It's possible to run a chi-square here yes, but it doesn't seem like an ideal choice in the sense that a chi-square test doesn't answer the question posed in this research (it looks at whether there is some difference between the two distributions, not whether the new technique was associated with fewer subsequent surgeries).
Matt aka CB | twitter.com/matthewmatix
Of course that probably describes oh about 90 percent of the social science analysis [can't speak for medical analysis]. Given that in most non-economic areas there is no theory to test even academics are going to just keep playing with the data to they find something that is significantCan I strongly suggest that you pre-register your protocol for data collection and analysis ahead of time for your next clinical trial? When you collect data and then only start to think about the analysis there is a major risk that (consciously or subconsiously) your data analytic decisions will be guided by whether a particular analysis method provides the findings you're hoping to see.
Even if you state your assumptions ahead of time, when they don't pan out you are going to run follow up theories....
"Very few theories have been abandoned because they were found to be invalid on the basis of empirical evidence...." Spanos, 1995
True, the Chi square test says there is some difference somewhere. Having established that, then you can do post hoc tests at each level, again using Chi square. (This is exactly the process you follow with an anova. Include Bonferroni if you like.)
So, here's a plan. Make three groups 1, 2, 3+ vs new, old, and test for some difference somewhere with a 3x2 Chi square. p = 0.0002 so yes, there is a difference somewhere.
At level 1, test old 14 vs new 35 with 1x2 Chi square. p = 0.003, so yes, new is significantly higher.
At level 2, test old 25 vs new 18 with 1x2 Chi square. p = 0.29, so can't really tell.
At level 3, test old 21 vs new 7 with 1x2 Chi square. p = 0.003, so yes, new is significantly lower.
It convinces me.
You don't need sophisticated theory to do an effective pre-registered study. In the case of a clinical trial the theory isn't necessarily going to be any more complicated than "the intervention works". The point is to specify your protocol for data collection and analysis prior to data collection so that readers don't have to wonder about whether you tailored your analysis in such a way as to produce significant effects.
Exploratory research is fine, but exploratory research dressed up as a confirmatory work and supported by p-hacking is a waste of everyone's time and money.
Uh, no. There are a lot of people out there who are aware of the reproducibility crisis and doing strong pre-registered studies (and accepting the results if the theory isn't supported) - there's effectively something of a revolution underway in terms of improving scientific practice in medicine and the social sciences. Try googling "registered replication reports".Even if you state your assumptions ahead of time, when they don't pan out you are going to run follow up theories....
For those who want to hunt around and explore follow-up theories that's fine, but then you need to label the work as exploratory and use suitable methods (generally not statistical significance testing).
Matt aka CB | twitter.com/matthewmatix
I'm sorry but I don't think this is at all an appropriate analysis. The study has a simple question - whether the intervention results in fewer subsequent surgeries. By trying to jam this into a chi-square framework you're ending up with multiple significance tests and having to jury-rig in a solution for familywise type 1 error. This just isn't the right way to do it - the OP needs a count-based regression model.
Matt aka CB | twitter.com/matthewmatix
To be clear I am not saying you should p hack. I think it is common. I know that at work when I test models that don't pan out I don't simply stop analyzing the data. I pull more variables in, transform the variables, create new theories, and use the same data I had, because it is the only data there is. In the world I live in you can't go out and gather new data because your original assumptions and theories were wrong. You have to try new theories you did not anticipate and you usually don't have the option of gathering new data. You either use what you have or you do no analysis. I suspect most use what they have even though that is problematic.
Last edited by noetsi; 01-31-2017 at 05:47 PM.
"Very few theories have been abandoned because they were found to be invalid on the basis of empirical evidence...." Spanos, 1995
This is true of some or even many academics but there also exist many academics who can and do report null findings (in both replications and original studies). Here's a massive example of many researchers working on a project that resulted in lots of null findings: http://science.sciencemag.org/content/349/6251/aac4716
Honestly, look up search terms like "reproducibility" or "pre-registered" or "questionable research practices" and you're going to find that this is a massive area of effort and change at the moment. Lots of us care about good science.
Pre-registration and reproducibility are covered in the one I teach. They are also covered in Daniel Lakens' MOOC, which had over 5000 students in its last iteration.It never came up in one of my statistical classes
Matt aka CB | twitter.com/matthewmatix
Tweet |